Altered serotonin (5-HT) 1D and 2A receptor expression may contribute to defective insulin and glucagon secretion in human type 2 diabetes.
about
Impact of Muscarinic M3 Receptor Antagonism on the Risk of Type 2 Diabetes in Antidepressant-Treated Patients: A Case-Controlled Study.Serotonin (5-HT) receptor 2b activation augments glucose-stimulated insulin secretion in human and mouse islets of Langerhans.Tryptophan Predicts the Risk for Future Type 2 DiabetesTherapeutic concentrations of antidepressants inhibit pancreatic beta-cell function via mitochondrial complex inhibition.In vivo imaging of beta cells with radiotracers: state of the art, prospects and recommendations for development and use.Gut: A key player in the pathogenesis of type 2 diabetes?Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney DiseaseHuman Beta Cells Produce and Release Serotonin to Inhibit Glucagon Secretion from Alpha Cells.
P2860
Q33845592-74D6FC9C-63EE-43E5-A3FA-B74A1CAAAA47Q35886138-19D06625-4529-44BF-AE87-BA75B691F7CFQ36123681-C9CBD783-F96E-42F7-B717-B14513BAFBC5Q38704329-F55A97D0-8DC8-407C-86A1-A28B90D9EF9FQ38812324-BD970B9A-EE45-40AB-B921-41FA0CE9AEC8Q39021924-EE783DB8-932A-418E-A7B8-8AF36F9BCD29Q41452150-BA59E15F-F815-4507-9F15-5296B191E855Q51240535-1C05AE16-1560-4A1B-8481-FCC86453148F
P2860
Altered serotonin (5-HT) 1D and 2A receptor expression may contribute to defective insulin and glucagon secretion in human type 2 diabetes.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Altered serotonin (5-HT) 1D an ...... tion in human type 2 diabetes.
@en
Altered serotonin
@nl
type
label
Altered serotonin (5-HT) 1D an ...... tion in human type 2 diabetes.
@en
Altered serotonin
@nl
prefLabel
Altered serotonin (5-HT) 1D an ...... tion in human type 2 diabetes.
@en
Altered serotonin
@nl
P2093
P50
P1433
P1476
Altered serotonin (5-HT) 1D an ...... tion in human type 2 diabetes.
@en
P2093
E Ottosson Laakso
M Dekker Nitert
P304
P356
10.1016/J.PEPTIDES.2015.07.008
P577
2015-07-20T00:00:00Z